Imfinzi (durvalumab) - AstraZeneca
Adstiladrin (nadofaragene firadenovec-vncg) - Ferring
Tecentriq (atezolizumab) - Roche
cretostimogene grenadenorepvec (CG0070) - CG Oncology
Anktiva (nogapendekin alfa inbakicept-pmln) - ImmunityBio
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/42260513
 
Abdulaziz Almanie; Abdullah Alammari; Ahmed Alasker; Mohammad Alghafees; Mohammed Alrashed; Naif Alanazi; Talah Nammor; Turki Alferayan; Yousef Almarzouq
 
Jun 10, 2026
 
Prev Next